The loss of the identity of insulin-secreting beta cells in the islet of Langerhans, a process also called beta cell dedifferentiation, has been proposed to be a main reason for the development of ...

New research (the Ver-A-T1D trial) presented at this year's Annual Meeting of the European Association for the Study of ...

Beta-blockers are still crucial for some, but new research calls into question the benefit for a large proportion of patients ...

SAN FRANCISCO —The glucagon-like peptide-1 (GLP-1) agonist liraglutide (Victoza, Novo Nordisk) taken every day preserved postprandial insulin secretion for 1 year after type 1 diabetes diagnosis in ...

The .NET library (formerly called .NET Core) doesn't have built-in functions for classical statistics analyses. But it is possible to implement such functions from scratch. This article presents C# ...

Please provide your email address to receive an email when new articles are posted on . Greater weight loss at 1 year with tirzepatide improved the odds for sustaining an HbA1c of 6.5% or less at 2 ...

New research (the Ver-A-T1D trial) presented at the Annual Meeting of the European Association for the Study of Diabetes ...

The loss of the identity of insulin-secreting beta cells in the islet of Langerhans, a process also called beta cell dedifferentiation, has been proposed to be a main reason for the development of ...

The REBOOT trial enrolled more than 8,400 patients recovering from a heart attack whose heart function was above 40% and assigned them to either take a beta blocker or no beta blocker within two weeks ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A restricted ...